本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Rallybio Corp.

0.2619
-0.0083-3.07%
盘前0.2467-0.0152-5.80%08:00 EDT
成交量:9.39万
成交额:2.45万
市值:1,089.82万
市盈率:-0.20
高:0.2699
开:0.2621
低:0.2510
收:0.2702
数据加载中...
2022/03/15

重要事件披露

8-K - Current report
2022/03/07

重要事件披露

8-K - Current report
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/08

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/21

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/18

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/11/10

重要事件披露

8-K - Current report
2021/11/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/09/09

重要事件披露

8-K - Current report
2021/09/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/12

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/08/12

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/08/12

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/08/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/08/02

重要事件披露

8-K - Current report
2021/08/02

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/07/26

SEC问询函

CORRESP [Cover] - Correspondence
2021/07/26

SEC问询函

CORRESP [Cover] - Correspondence
2021/07/22

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933